These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 38228603)

  • 1. Lung microbiome: new insights into the pathogenesis of respiratory diseases.
    Li R; Li J; Zhou X
    Signal Transduct Target Ther; 2024 Jan; 9(1):19. PubMed ID: 38228603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Human Respiratory Microbiome: Current Understandings and Future Directions.
    Zhao L; Luo JL; Ali MK; Spiekerkoetter E; Nicolls MR
    Am J Respir Cell Mol Biol; 2023 Mar; 68(3):245-255. PubMed ID: 36476129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lung mycobiome: an emerging field of the human respiratory microbiome.
    Nguyen LD; Viscogliosi E; Delhaes L
    Front Microbiol; 2015; 6():89. PubMed ID: 25762987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens.
    Santoro A; Tomino C; Prinzi G; Cardaci V; Fini M; Macera L; Russo P; Maggi F
    Curr Med Chem; 2020; 27(18):2931-2948. PubMed ID: 31838985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional effects of the microbiota in chronic respiratory disease.
    Budden KF; Shukla SD; Rehman SF; Bowerman KL; Keely S; Hugenholtz P; Armstrong-James DPH; Adcock IM; Chotirmall SH; Chung KF; Hansbro PM
    Lancet Respir Med; 2019 Oct; 7(10):907-920. PubMed ID: 30975495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.
    Mendez R; Banerjee S; Bhattacharya SK; Banerjee S
    IUBMB Life; 2019 Feb; 71(2):152-165. PubMed ID: 30466159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    Wang L; Hao K; Yang T; Wang C
    Chin Med J (Engl); 2017 Sep; 130(17):2107-2111. PubMed ID: 28741603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral-lung microbiome interactions in lung diseases.
    Mammen MJ; Scannapieco FA; Sethi S
    Periodontol 2000; 2020 Jun; 83(1):234-241. PubMed ID: 32385873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbiome of the lung.
    Beck JM; Young VB; Huffnagle GB
    Transl Res; 2012 Oct; 160(4):258-66. PubMed ID: 22683412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Winds of change a tale of: asthma and microbiome.
    Galeana-Cadena D; Gómez-García IA; Lopez-Salinas KG; Irineo-Moreno V; Jiménez-Juárez F; Tapia-García AR; Boyzo-Cortes CA; Matías-Martínez MB; Jiménez-Alvarez L; Zúñiga J; Camarena A
    Front Microbiol; 2023; 14():1295215. PubMed ID: 38146448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease.
    Tiew PY; Mac Aogáin M; Chotirmall SH
    Curr Opin Pulm Med; 2022 Mar; 28(2):121-133. PubMed ID: 34839338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases.
    Chellappan DK; Sze Ning QL; Su Min SK; Bin SY; Chern PJ; Shi TP; Ee Mei SW; Yee TH; Qi OJ; Thangavelu L; Rajeshkumar S; Negi P; Chellian J; Wadhwa R; Gupta G; Collet T; Hansbro PM; Dua K
    Chem Biol Interact; 2019 Sep; 310():108732. PubMed ID: 31276660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lung microbiome: progress and promise.
    Whiteside SA; McGinniss JE; Collman RG
    J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34338230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gut Microbiota and Respiratory Diseases: New Evidence.
    Chunxi L; Haiyue L; Yanxia L; Jianbing P; Jin S
    J Immunol Res; 2020; 2020():2340670. PubMed ID: 32802893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizations of the Gut Bacteriome, Mycobiome, and Virome in Patients with Osteoarthritis.
    Chen C; Zhang Y; Yao X; Li S; Wang G; Huang Y; Yang Y; Zhang A; Liu C; Zhu D; Li H; Yan Q; Ma W
    Microbiol Spectr; 2023 Feb; 11(1):e0171122. PubMed ID: 36515546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes of gut and lung microorganisms during chronic obstructive pulmonary disease exacerbations.
    Sun Z; Zhu QL; Shen Y; Yan T; Zhou X
    Kaohsiung J Med Sci; 2020 Feb; 36(2):107-113. PubMed ID: 31782610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiomes in respiratory health and disease: An Asia-Pacific perspective.
    Chotirmall SH; Gellatly SL; Budden KF; Mac Aogain M; Shukla SD; Wood DL; Hugenholtz P; Pethe K; Hansbro PM
    Respirology; 2017 Feb; 22(2):240-250. PubMed ID: 28102970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis.
    Avalos-Fernandez M; Alin T; Métayer C; Thiébaut R; Enaud R; Delhaes L
    Respir Res; 2022 Aug; 23(1):214. PubMed ID: 35999634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung microbiome, gut-lung axis and chronic obstructive pulmonary disease.
    Gokulan K; Joshi M; Khare S; Bartter T
    Curr Opin Pulm Med; 2022 Mar; 28(2):134-138. PubMed ID: 34907959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.